Cargando…
TMEM2 induces epithelial-mesenchymal transition and promotes resistance to temozolomide in GBM cells
Glioblastoma multiforme (GBM) is the most common intracranial malignant tumor and is notorious for its poor prognosis. An important element in the short overall survival of GBM patients is the lack of understanding the pathogenesis and progression of tumor and deficiency biomarkers that can be used...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245174/ https://www.ncbi.nlm.nih.gov/pubmed/37292284 http://dx.doi.org/10.1016/j.heliyon.2023.e16559 |